Thea Eline Hetland Falkenthal
forsker, Lege, spesialist i kreftsykdommer. PhD
Kontakt
Mob: 229 28 853
Send e-post {model.translations.sendEmailTo} Thea.Eline.Hetland.Falkenthal@fhi.no
Avdeling
Fagområder
Onkologi Gynekologi HPV Vaksiner
Prosjekter og publikasjoner
- Ståle Nygård, Thea Eline Hetland Falkenthal, Tina Drivenes Sture, Elsebeth Lynge, Miriam Klara Elfström, Mari Kiens Nygård, (2024). Impact of Multicohort Human Papillomavirus Vaccination on Cervical Cancer in Women Below 30 Years of Age: Lessons Learned From the Scandinavian Countries. Journal of Infectious Diseases doi: 10.1093/infdis/jiae584
- Susanne K. Kjaer, Thea Eline Hetland Falkenthal, Karin Sundström, Christian Munk, Tina Drivenes Sture, Oliver Bautista, Thomas Group, Sonali Rawat, Alain Luxembourg, (2024). Long-term effectiveness of the nine-valent human papillomavirus vaccine: Interim results after 12 years of follow-up in Scandinavian women. Human Vaccines & Immunotherapeutics doi: 10.1080/21645515.2024.2377903
- Christian Arvei Moen, Thea Eline Hetland Falkenthal, Tor Kristian Torkelsen, Anders Mølster Hopland, Oline Eriksen Rio, Alfred Honore, Patrick Juliebø-Jones, Harsh Nitin Dongre, Daniela Elena Costea, Leif Henry Bostad, Paul Brennan, Mattias Johansson, Aida Feirrero-Iglesias, Nicole Brenner, Tim Waterboer, Mari Nygård, Christian Beisland, (2023). Penile Cancers Attributed to Human Papillomavirus Are Associated with Improved Survival for Node-positive Patients. Findings from a Norwegian Cohort Study Spanning 50 Years. European Urology Oncology (EUO) s. 778-785. doi: 10.1016/j.euo.2023.10.013
- Hadil Onallah, Liora Jacobs Catane, Claes Gøran Tropé, Thea Eline Hetland Falkenthal, Reuven Reich, Ben Davidson, (2018). Activity and clinical relevance of autotaxin and lysophosphatidic acid pathways in high-grade serous carcinoma. Virchows Archiv doi: 10.1007/s00428-018-2418-x
- Ben Davidson, Marianne Bjørnerem, Arild Holth, Ellen Hellesylt, Thea Eline Hetland Falkenthal, Vivi Ann Flørenes, (2018). Expression, activation and clinical relevance of CHK1 and CHK2 in metastatic high-grade serous carcinoma. Gynecologic Oncology s. 136-142. doi: 10.1016/j.ygyno.2018.05.007
- Ben Davidson, Arild Holth, Zhihui Wang, Ellen Hellesylt, Claes Gøran Tropé, Thea Eline Hetland Falkenthal, Ruth Holm, (2018). Expression of 14-3-3 sigma and eta proteins is unrelated to survival in metastatic high-grade serous carcinoma. APMIS - Journal of Pathologiy, Microbiology and Immunology s. 309-313. doi: 10.1111/apm.12816
- Natalie Filippov-Levy, Hallel Cohen-Schussheim, Claes Gøran Tropé, Thea Eline Hetland Falkenthal, Yoav Smith, Ben Davidson, Reuven Reich, (2018). Expression and clinical role of long non-coding RNA in high-grade serous carcinoma. Gynecologic Oncology s. 559-566. doi: 10.1016/j.ygyno.2018.01.004
- Dag Andre Nymoen, Ana Slipicevic, Arild Holth, Elisabeth Emilsen, Thea Eline Hetland Falkenthal, Claes Gøran Tropé, Reuven Reich, Vivi Ann Flørenes, Ben Davidson, (2016). Mir-29a is a candidate biomarker of better survival in metastatic high-grade serous carcinoma. Human Pathology s. 74-81. doi: 10.1016/j.humpath.2016.03.010
- Dag Andre Nymoen, Arild Holth, Thea Eline Hetland, Claes Gøran Tropé, Ben Davidson, (2015). CIAPIN1 and ABCA13 are markers of poor survival in metastatic ovarian serous carcinoma. Molecular Cancer s. 1-9. doi: 10.1186/s12943-015-0317-1
- Dag Andre Nymoen, Thea Eline Hetland Falkenthal, Arild Holth, Ghim Siong Ow, Anna V. Ivshina, Claes Gøran Tropé, Vladimir Kuznetsov, Anne Cathrine Staff, Ben Davidson, (2015). Expression and clinical role of chemoresponse-associated genes in ovarian serous carcinoma. Gynecologic Oncology s. 30-39. doi: 10.1016/j.ygyno.2015.07.107
- Ben Davidson, Dag Andre Nymoen, Bente Vilming Elgaaen, Anne Cathrine Staff, Claes Gøran Tropé, Janne Kærn, Reuven Reich, Thea Eline Hetland, (2014). BUB1 mRNA is significantly co-expressed with AURKA and AURKB mRNA in advanced-stage ovarian serous carcinoma. Virchows Archiv s. 701-707. doi: 10.1007/s00428-014-1577-7
- Helene Tuft Stavnes, Dag Andre Nymoen, Thea Eline Hetland, Janne Kærn, Claes Gøran Tropé, Ben Davidson, (2014). APOA1 mRNA expression in ovarian serous carcinoma effusions is a marker of longer survival. American Journal of Clinical Pathology s. 51-57. doi: 10.1309/AJCPD8NBSHXRXQL7
- Mouldy Sioud, Stein Sæbøe-Larssen, Thea Eline Hetland, Janne Kærn, Anne Mobergslien, Gunnar Kvalheim, (2013). Silencing of indoleamine 2,3-dioxygenase enhances dendritic cell immunogenicity and antitumour immunity in cancer patients. International Journal of Oncology s. 280-288. doi: 10.3892/ijo.2013.1922
- Riyas M Vettukattil, Thea Eline Hetland, Vivi Ann Flørenes, Janne Kærn, Ben Davidson, Tone Frost Bathen, (2013). Proton magnetic resonance metabolomic characterization of ovarian serous carcinoma effusions: chemotherapy-related effects and comparison with malignant mesothelioma and breast carcinoma. Human Pathology s. 1859-1866. doi: 10.1016/j.humpath.2013.02.009
- Thea Eline Hetland, Dag Andre Nymoen, Arild Holth, Kjersti Brusegard, Vivi Ann Flørenes, Janne Kærn, Claes Gøran Tropé, Ben Davidson, (2013). Aurora B expression in metastatic effusions from advanced-stage ovarian serous carcinoma is predictive of intrinsic chemotherapy resistance. Human Pathology s. 777-785. doi: 10.1016/j.humpath.2012.08.002
- Olga Vaksman, Thea Eline Hetland, Claes Gøran Tropé, Reuven Reich, Ben Davidson, (2012). Argonaute, Dicer, and Drosha are up-regulated along tumor progression in serous ovarian carcinoma. Human Pathology s. 2062-2069. doi: 10.1016/j.humpath.2012.02.016
- Thea Eline Hetland, Janne Kærn, Martina Skrede, Berit Sandstad, Claes Gøran Tropé, Ben Davidson, Vivi Ann Flørenes, (2012). Predicting platinum resistance in primary advanced ovarian cancer patients with an in vitro resistance index. Cancer Chemotherapy and Pharmacology s. 1307-1314. doi: 10.1007/s00280-012-1835-9
- Thea Eline Hetland, Dag Andre Nymoen, Elisabeth Emilsen, Janne Kærn, Claes Gøran Tropé, Vivi Ann Flørenes, Ben Davidson, (2012). MGST1 expression in serous ovarian carcinoma differs at various anatomic sites, but is unrelated to chemoresistance or survival. Gynecologic Oncology s. 460-465. doi: 10.1016/j.ygyno.2012.05.029
- Thea Eline Hetland, Arild Holth, Janne Kærn, Vivi Ann Flørenes, Claes Gøran Tropé, Ben Davidson, (2012). HMGA2 protein expression in ovarian serous carcinoma effusions, primary tumors, and solid metastases. Virchows Archiv s. 505-513. doi: 10.1007/s00428-012-1228-9
- Kjersti Brenne, Dag Andre Nymoen, Thea Eline Hetland, Claes Gøran Tropé, Ben Davidson, (2012). Expression of the Ets transcription factor EHF in serous ovarian carcinoma effusions is a marker of poor survival. Human Pathology s. 496-505. doi: 10.1016/j.humpath.2011.05.023
- Geoffrey Kim, Ben Davidson, Ryan Henning, Junbai Wang, Minshu Yu, Christina Annunziata, Thea Eline Hetland, Elise C. Kohn, (2012). Adhesion molecule protein signature in ovarian cancer effusions is prognostic of patient outcome. Cancer s. 1543-1553. doi: 10.1002/cncr.26449
- Murat Gultekin, Polat Dursun, Boris Vranes, Rene Laky, Michaela Bossart, Jacep P. Grabowski, Jurgen M.J. Piek, Ranjit Manchanda, Christoph Grimm, Kastriot Dallaku, Syuzanna Babloyan, Anna Moisei, Toon Van Gorp, Isabelle Cadron, Peter Markov, Ana Micevska, Michael Halaska, Karina Dahl Steffensen, Liidia Gristsenko, Ritva Nissi, Eric Lambaudie, Zaza Tsitsishvili, Dimitrios Haidopoulos, Dimitrios Tsolakidis, Zoltan Novak, Michele Peiretti, Gauhar Dunenova, Ronalds Macuks, Thea Eline Hetland, Trond Melbye Michelsen, Filipe C. Martins, Patriciu Achimas-Cadariu, Elena A. Ulrikh, Peter Uharcek, Sladjana Malic, Dejan Ognjenovic, Ignacio Zapardiel, Silke Johann, Vladyslav S. Sukhin, Rajesh V. Manchanda, (2011). Gynecologic Oncology Training Systems in Europe A Report From the European Network of Young Gynaecological Oncologists. International Journal of Gynecological Cancer s. 1500-1506. doi: 10.1097/IGC.0b013e3182202d17
- Thea Eline Hetland, Ellen Hellesylt, Vivi Ann Flørenes, Claes Gøran Tropé, Ben Davidson, Janne Kærn, (2011). Class III beta-tubulin expression in advanced-stage serous ovarian carcinoma effusions is associated with poor survival and primary chemoresistance. Human Pathology s. 1019-1026. doi: 10.1016/j.humpath.2010.10.025
- Thea Eline Hetland Falkenthal, (2024). Kreftregisterets rolle i forskning om HPV-vaksinene Gardasil og Gardasil9. Onkonytt
- Mari Nygård, Emily Annika Burger, Ståle Nygård, Ameli Tropé, Thea Eline Hetland Falkenthal, Jannicke Mohr Berland, Line Bjørge, Ane Cecilie Dæhli Munk, Knut Hordnes, Giske Ursin, (2023). Skal vi screene og konisere inn i evigheten – eller bytte HPV-vaksine?. dagensmedisin.no